Published in Zhonghua Zhong Liu Za Zhi on December 01, 2006
Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer (2009) 1.92
Stathmin is a marker of progression and poor prognosis in esophageal carcinoma. Asian Pac J Cancer Prev (2014) 1.42
Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. World J Gastroenterol (2003) 1.37
miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. Stem Cells Dev (2014) 1.11
A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma. BMC Cancer (2011) 1.10
The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate. Vaccine (2009) 1.00
Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep (2011) 0.98
ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis. Biochem Biophys Res Commun (2003) 0.96
The role of pre-replicative complex (pre-RC) components in oncogenesis. FASEB J (2007) 0.96
Genomic profiling of 766 cancer-related genes in archived esophageal normal and carcinoma tissues. Int J Cancer (2008) 0.95
Dysregulated expression of dicer and drosha in breast cancer. Pathol Oncol Res (2011) 0.94
Clinical classification of Caroli's disease: an analysis of 30 patients. HPB (Oxford) (2014) 0.94
Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. World J Gastroenterol (2012) 0.92
Combining Oxymatrine or Matrine with Lamivudine Increased Its Antireplication Effect against the Hepatitis B Virus In Vitro. Evid Based Complement Alternat Med (2013) 0.91
Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1. J Cell Biochem (2004) 0.87
ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability. J Biol Chem (2007) 0.87
HDAC inhibitor trichostatin A suppresses esophageal squamous cell carcinoma metastasis through HADC2 reduced MMP-2/9. Clin Invest Med (2013) 0.86
Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy. Cancer Sci (2014) 0.86
Molecular cloning and characterization of a novel esophageal cancer related gene. Int J Oncol (2010) 0.85
ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway. J Biol Chem (2009) 0.85
Expression of N-cadherin in esophageal squamous cell carcinoma and silencing expression of N-cadherin using RNA interference on invasiveness of EC9706 cells. Ai Zheng (2009) 0.85
Downregulation of N-cadherin expression inhibits invasiveness, arrests cell cycle and induces cell apoptosis in esophageal squamous cell carcinoma. Cancer Invest (2010) 0.84
Short tandem repeat polymorphism in a novel esophageal cancer-related gene (ECRG2) implicates susceptibility to esophageal cancer in Chinese population. Int J Cancer (2004) 0.83
Mapping the putative binding site for uPA protein in Esophageal Cancer-Related Gene 2 by heteronuclear NMR method. Arch Biochem Biophys (2008) 0.83
N-cadherin knock-down decreases invasiveness of esophageal squamous cell carcinoma in vitro. World J Gastroenterol (2009) 0.82
ECRG1, a novel candidate of tumor suppressor gene in the esophageal carcinoma, triggers a senescent program in NIH3T3 cells. Exp Biol Med (Maywood) (2006) 0.82
Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma. J Surg Oncol (2011) 0.81
ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration. Cancer Lett (2009) 0.81
Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A. Biochimie (2010) 0.81
Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F. Clin Immunol (2010) 0.80
Using yeast two-hybrid system to identify ECRG2 associated proteins and their possible interactions with ECRG2 gene. World J Gastroenterol (2003) 0.79
SNCG shRNA suppressed breast cancer cell xenograft formation and growth in nude mice. Chin Med J (Engl) (2011) 0.79
Identification of a novel polymorphism Arg290Gln of esophageal cancer related gene 1 (ECRG1) and its related risk to esophageal squamous cell carcinoma. Carcinogenesis (2005) 0.79
PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis. Asian Pac J Cancer Prev (2015) 0.79
[Prophylactic effect of amifostine on oxaliplatin-related neurotoxicity in patients with digestive tract tumors]. Ai Zheng (2008) 0.79
Immunization of mice with a DNA vaccine based on severe acute respiratory syndrome coronavirus spike protein fragment 1. Viral Immunol (2006) 0.78
[Mechanism of apoptosis of esophageal cancer EC9706 in nude mice induced by all-trans retinoic acid]. Zhonghua Zhong Liu Za Zhi (2010) 0.78
Protection with a recombinant Hc of Clostridium Botulinum neurotoxin serotype A from Escherichia coli as an effective subunit vaccine. Immunopharmacol Immunotoxicol (2009) 0.77
[Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia]. Zhonghua Yi Xue Za Zhi (2007) 0.77
Monoclonal antibodies to esophageal cancer-related gene2 protein. Hybridoma (Larchmt) (2005) 0.77
MYC and MXI1 protein expression: potential prognostic significance in women with breast cancer in China. Oncol Res Treat (2014) 0.77
Anti-resorptive effect of pilose antler blood (Cervus nippon Temminck) in ovariectomized rats. Indian J Exp Biol (2010) 0.77
N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry. Med Oncol (2015) 0.77
[Apoptosis in esophageal cancer cells induced by all-trans retinoic acid]. Zhonghua Zhong Liu Za Zhi (2007) 0.76
Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine. Clin Vaccine Immunol (2008) 0.76
[Inhibitory effect of Oridonin injection on heterotransplanted gastric adenocarcinoma in nude mice and its mechanism]. Zhonghua Zhong Liu Za Zhi (2008) 0.76
Synuclein-γ suppression mediated by RNA interference inhibits the clonogenicity and invasiveness of MCF-7 cells. Oncol Lett (2013) 0.76
Intake of volatile N-nitrosamines and their ability to exogenously synthesize in the diet of inhabitants from high-risk area of esophageal cancer in southern China. Biomed Environ Sci (2002) 0.76
Effects of endothelin-1 on the cytoskeleton protein F-actin of human trabecular meshwork cells in vitro. Int J Ophthalmol (2010) 0.75
The influence of He-Ne laser on scar formation after trabeculectomy in rabbits. Int J Ophthalmol (2010) 0.75
[Ecological risk assessment of heavy metals in surface sediments in the southern and central Haihe River Basin]. Huan Jing Ke Xue (2014) 0.75
Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial. Chin Med J (Engl) (2011) 0.75
[Efficacy of gemcitabine with concurrent radiotherapy on stage III,inoperable non-small cell lung cancer]. Ai Zheng (2007) 0.75
[Therapeutic effect of docetaxel combined with oxaliplatin for treatment of recurrent epithelial ovarian cancer]. Nan Fang Yi Ke Da Xue Xue Bao (2009) 0.75
[Upper eyelid reconstruction with forehead skin flap with base at the supraorbital artery region]. Zhonghua Yan Ke Za Zhi (2012) 0.75
[Construction and expression of human stathmin gene eukaryotic expression vector and its effect on esophageal cancer cells]. Zhonghua Zhong Liu Za Zhi (2008) 0.75
[Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro]. Zhonghua Zhong Liu Za Zhi (2011) 0.75
RNAi-induced K-Ras gene silencing suppresses growth of EC9706 cells and enhances chemotherapy sensitivity of esophageal cancer. Asian Pac J Cancer Prev (2012) 0.75
[Efficacy of DACE regimen on relapsed and refractory non-Hodgkin's lymphoma]. Ai Zheng (2008) 0.75
[Microcalorimetric investigation on the interaction of six alkaloids from rhizoma coptidis]. Yao Xue Xue Bao (2013) 0.75
[Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer]. Zhonghua Zhong Liu Za Zhi (2008) 0.75
Therapeutic regimens and prognostic factors of brain metastatic cancers. Asian Pac J Cancer Prev (2013) 0.75